A Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis
Status:
NOT_YET_RECRUITING
Trial end date:
2029-09-30
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the safety of F8IL10 when administered by intra-articular injection and to determine the maximum tolerated dose (MTD) in order to establish the recommended dose (RD) in patients with Reumatoid Arthritis.